The products of three genes are involved in cyanocobalamin (B12) uptake in Escherichia coli. btuB (formerly bfe), located at min 88 on the Escherichia coli linkage map, codes for a protein component of the outer membrane which serves as receptor for B12, the E colicins, and bacteriophage BF23. Four phenotypic classes of mutants varying in response to these agents were found to carry mutations that, based on complementation and reversion analyses, reside in the single btuB cistron. In one mutant class, ligand binding to the receptor appeared to be normal, but subsequent B12 uptake was defective. The level of receptor and rate of uptake were responsive to btuB gene dosage. Previous studies showed that the tonB product was necessary for energy-dependent B12 uptake but not for its binding. Other than those in tonB, no mutations that conferred insensitivity to group B colicins affected B12 utilization. The requirement for the btuB and tonB products could be bypassed by elevated levels of B,2 (>1 1iM) or by mutations compromising the integrity of the outer membrane as a permeability barrier. Utilization of elevated B12 concentrations in strains lacking the btuBtonB uptake system was dependent on the function of the btuC product. This gene was located at 37.7 min on the linkage map, with the order pps-btuC-pheS. Strains altered in btuC but with an intact btuB-tonB system were only slightly impaired in B12 utilization, being defective in its accumulation. This defect was manifested as inability to retain B12, such that intracellular label was almost completely lost by exchange or efflux. It is proposed that btuC encodes a transport system for B12 in the periplasm.
Cyanocobalamin (B12) uptake by Escherichia coli is a biphasic process. The rapid, energyindependent initial phase represents binding to a receptor protein in the outer membrane of the cell envelope, and is followed by a slower, energy-dependent phase of B12 accumulation in the cell (9, 27, 30) . The receptor protein is also involved in specific binding of the E colicins and bacteriophage BF23 (11) . There is competition for binding to the cells or receptor among these three classes of ligands, and most mutants selected for resistance to these colicins or phage are deficient in B12 binding and transport (18) . The binding activities reside in a 60,000-dalton protein present in 200 to 300 copies per cell (25, 30) . Little is known about steps of B12 uptake subequent to binding to the receptor other than that accumulation is energized by the protonmotive gradient (3) . The secondary, but not the initial, phase of uptake is dependent on the function of the tonB gene product (2) .
Isolation of mutants defective in either phase of B12 uptake, by selection for decreased B12 (10) . The associated mutations were mapped adjacent to one another at 88 min on the revised linkage map (1) . It was proposed (18) , based on their different phenotypic properties, that the mutants carried lesions in two separate genetic loci. One class (termed BtuA, now BtuI) had normal binding activities but lacked the secondary phase of uptake. The other class (termed BtuB) had an altered receptor, being resistant to the E colicins and phage BF23 and lacking both phases of B12 uptake. The genetic location was very near that of the previously described bfe locus, encoding receptor for the E colicins and phage BF23 (5, 11, 16) .
We describe here the genetic basis for the various phenotypic manifestations of mutations in btuB. From complementation, reversion, and localized comutagenesis analyses, we conclude that all of the phenotypes result from alterations within the same cistron. Although it was origi-VOL. 132, 1977 to mutation at btuB or tonB were able to utilize higher levels of B12. We define here the btuC locus, whose product plays a role in the response to B12 by some means independent of the btuBtonB uptake system.
MATERIALS AND METHODS
Bacterial strains, media, and chemicals. The strains of E. coli K-12 employed are listed in Tables  1 and 2 . Isolation of TonB-mutants and mutants resistant to the E colicins or phage BF23 has been described previously (2, 18) . Common procedures for transduction mediated by phage P1 and for mutagenesis with phage Mu-1 or N-methyl-N'-nitro-Nnitrosoguanidine were employed (21) . Bacteriophages Plvir, Mu-1, T4, and T7 are maintained as laboratory stocks. Colicin E3 was prepared and diluted in L broth as decribed previously (17) . The minimal growth medium was medium A of Davis and Mingioli (8) supplemented with glucose (0.5%), required amino acids (100 ,ug/ml), thiamine (1 jig/ml), and B12 as specified. MeStrain   KL96  Ra-2  RK4101  RK4102  RK4103  RK4113  RK4117  RK4118  RK4119  RK4120  RK4121  RK4122  RK4123  RK4124  KBT101  KBT103  RK4136  RK4137  RK4138  RK4139  RK4140  RK4141  RK4142  RK4143  RK4144  RK4145  RK4150  RK4152  RK4154  RK4156  RK4158  RK4151  RK4196  RK4197  BW183  RK4527  RK4528  RK4529  KL162   GENETICS OF B12 Hfr thi-1 rel-1 Hfr supE42 mal-28 F-metE argHl proC lysA leu tonA rpsL rpoB tsx As RK4101 but arg+ btuB451 Aa RK4101 but arg+ btuB452 As RK4101 but rpoB+ As RK4113 but non As RK4117 but arg+ btuB451 As RK4117 but arg+ btuB454 As RK4101 but lys+ recA thyA As RK4101 but btuB454 As RK4101 but btuB::Mu As RK4113 but btuB458 rpoB As RK4113 but btuB459 rpoB F-metE proC lysA leu trp purE tonA rpsL tsx btuC456 As KBT101 but btuC457 F-metE argE pyrE60 rpsL btuC455 As RK4136 but btuC+ As RK4137 but arg+ btuB452 As RK4136 but arg+ btuB452 As RK4137 but arg+ butB454 As RK4136 but arg+ btuB454 As RK4137 but tonB2 As RK4136 but tonB2 As RK4137 but tonB15 As RK4136 but tonB15 As RK4113 but lys+ recAl As RK4150 but rpoB btuB451 As RK4150 but rpoB butB452 As RK4150 but rpoB btuB454 As RK4150 but rpoB btuB458 RK4150/F' argH+ btuB+ rpoB+ F-metE pyrE60 rpsL btuC+ As RK4196 but btuC455 F-pabB3 pps-2 pheS1l nadB30 As KBT101 but btuB (tonB-trp)A As KBT103 but btuB (tonB-trp)A As RK4527 but btuC+ pps-2 pheS1 Hfr thi thyA recAl Mu-i insertion in btuB 10 10 Derived from RK1034 (19) Transduction from RK4103 Localized mutagenesis in the rpoB region. Since the defect in BtuI mutants was located near mutations in BtuII strains (18) , the possible presence of several cistrons involved with B12 uptake was investigated by employment of the comutagenesis procedure described by Oeschger and Berlyn (22) . Strain RK4113 was treated with nitrosoguanidine, and rifampin-resistant mutants were selected and scored for defects in B12 utilization. Several were unable to respond to B12 at any concentration. Their normal B12 uptake and growth in the presence of B12 plus homocysteine indicated that they were defective in one of the methionine biosynthetic enzymes whose structural genes are near rpoB. Both BtuII and BtuIII mutants were obtained (46 of 4,000). None with a BtuI phenotype was found.
Two mutants exhibited unusual behavior (BtuIV). They lacked both phases of B12 uptake but remained sensitive to the E colicins and phage BF23. Even though there was little or no detectable binding of B12, it still protected these cells against all three E colicins at least as well as in a Btu' strain.
Complementation analysis with merodiploid strains. All mutations conferring the BtuI, II, III, or IV phenotype were located between argH and rpoB (38 to 72% cotransduction with argH). To investigate the number of cistrons involved in B12 uptake, merodiploid strains were constructed combining representative alleles that confer the five Btu phenotypes.
Whenever one allele in the merodiploid strains was btuB+, the strain was sensitive to colicin E3 and phage BF23 and grew normally at 5 and 0.5 nM B12 ( Bypass of B12 receptor. The marked decrease in B12 uptake upon loss of btuB-coded receptor activity signified that the outer membrane represented a considerable barrier for B12.
Mutants in which the barrier function of the outer membrane has been compromised might respond more efficiently to B12 in the absence of receptor. Many classes of mutants, including some phage T4-resistant strains, are said to possess "leaky" outer membranes. This defect in barrier function is manifested as increased sensitivity to certain antibiotics and detergents (12, 26) .
A considerable number of phage T4-resistant derivatives of strain RK4121 (BtuIII) grew well at 50 nM B12 ( The order of several genes in this region of the chromosome has been determined (28, 29) . The location of btuC with respect to some of these markers was determined by phage P1-mediated transduction. The btuC recipient strains, carrying mutations in metE, btuB, and tonB, were unable to utilize B12. Phage P1 propagated on strain BW183 (pheS pps pabB) donated the ability to utilize 5 .tM B12. Of the MetE-BtuC+ recombinants, approximately 90% had inherited the donor pheS marker, 64% had inherited the donor pps marker, and none had inherited the donor pabB marker (Table 6) . A recombinant carrying mutations in pheS and pps (as well as in metE, btuB, and tonB) was transduced to pps+ (growth on lactate as the sole carbon source) with P1 phage propagated on any of three strains that exhibited the BtuC-phenotype. Identity of the minority class of recombinants and cotransduction frequencies were consistent only with the gene order: pps-btuC-pheS (Table 5 ). btuC was placed at 37.7 min on the linkage map, approximately 0.16 min from pps and 0.08 min from pheS. Identical locations were deduced from crosses with all three btuC alleles or with apheS(Ts)5 allele as the selective marker.
Growth properties of BtuC-mutants. B12 utilization was determined in isogenic strains differing at btuC and carrying other mutations affecting B12 uptake (Table 7) . Both btuB (I, II, or III) btuC and tonB btuC double mutants were unable to utilize B12, even at 0.5 mM. Mutation at btuC did not affect the response to a number of antibiotics and detergents. Although the btuC mutation did not affect growth of Btu' TonB' strains on 5 nM B12, utilization of lower concentrations was impaired. A btuC' strain achieved half-maximal growth rate with 0.24 nM B12, whereas a btuC strain required 4 nM B12 for comparable growth. Both strains had the same growth rate on 30 nM B12 or methionine (65 min).
When btuC+ strain RK4196 was grown overnight on 50 nM B12 and then was washed and suspended in minimal growth medium lacking a methionine source, it underwent almost five doublings before methionine limitation occurred. Under identical conditions, btuC strain RK4197 underwent only one doubling. Cells of either strain grown overnight with methionine increased by less than 50%. This suggested that BtuC-mutants were impaired either in accumulation or retention of B12.
B12 uptake in btuC strains. Binding and uptake of B12 were measured in strains differing at btuC. Amounts of B12 bound to energy-poisoned cells were essentially identical. Energydependent B12 uptake clearly differed (Fig. 3) . Initial rates of uptake were fairly similar, but a marked disparity was apparent at later times in the uptake process. B12 was extensively accumulated by the btuC+ strain, whereas uptake reached a plateau in btuC strains.
Exchange and chase experiments indicated that the defect might not be at the influx stage but in retention of substrate. Addition of excess unlabeled B12 after a period of substrate accumulation resulted in loss of the label (Fig. 3) Existence of a btuB-tonB-independent B12 uptake system is obvious from the utilization of high levels of Bl, in mutants carrying deletions or phage Mu-I insertions in these genes. Moderate disruption of the barrier properties of the outer membrane enhanced B12 utilization by this low-affinity system. The btuC product is a component of this system, since mutants altered in this gene totally lack btuB-tonB-independent uptake or utilization. Since strains altered only in btuC are not seriously impaired in B12 utilization, this product is probably not necessary for the function of the btuB-tonB uptake system, for metabolism of B12 to coenzyme forms, or for formation of other intermediates in methionine biosysthesis. Derangement of the outer membrane did not bypass the defect in BtuC-. The results point to the existence of a btuC-coded B12 uptake system in the cytoplasmic membrane, independent of the btuB-tonB uptake system and acting on substrate in the periplasm.
The apparent lower efficiency of this system and the lack of appreciable uptake of labeled B12 by btuB or tonB mutants underscore the low rate of B12 permeation across the outer membrane in absence of receptor.
The observed effect of btuC alteration on B12 uptake can be accounted for with several ad hoc assumptions. Assume that B12 accumulation represents a summation of influx and efflux steps and that influx via the btuB-tonB system acts only on extracellular substrate, but that efflux via this system releases substrate both to the periplasm and the extracellular space. Then, the lack of a system able to take up periplasmic substrate would be manifested as a lower steadystate level and more extensive loss by exchange, both of which are observed. Kinetic parameters of low-affinity uptake cannot be measured in cells owing to lack of knowledge concerning the periplasmic concentration of substrate and the rate of B12 diffusion through nonspecific pores in the outer membrane.
Several points concerning the genetic location of btuC are noteworthy. btuC is almost exactly a number of other cistrons involved with vitamin synthesis or transport. Almost half of the known operons coding some step of vitamin metabolism are located in the two 5-min segments flanking btuB and btuC (17 loci between 85 and 90 min, and 5 loci between 35 and 40 min [1] ).
The substrate specificity of low-affinity B12 uptake from the periplasm is unknown. It is difficult to propose the selective advantage for the existence of two independent systems specific for a substrate that is neither synthesized nor required. It has been proposed that ferricenterochelin can be transported from the periplasm without participation of specific receptor in the outer membrane or tonB product (14) , although both proteins are necessary for efficient uptake from the medium (15, 23) . Possible involvement of btuC product in iron uptake is under study. One possibly important point from the properties of BtuC-strains is that B12 uptake from the periplasm, mediated by btuC product, does not appear to be a part of receptor-mediated uptake via the btuB-tonB system.
